CBMT-03. A NOVEL METABOLIC PET TRACER STRATEGY TO DETERMINE EARLY EFFECTS OF TUMOR TREATING FIELDS (TTFIELDS)

Pyruvate kinase M2 (PKM2) is a key marker of cancer metabolic reprogramming since it catalyzes the final step in glycolysis. [18F]DASA-23 is a novel radiotracer that measures aberrantly-expressed PKM2 in glioblastoma (GBM). Tumor treating fields (TTFields), the application of alternating electric fi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Patel, Chirag, Beinat, Corinne, Xie, Yuanyang, Haywood, Tom, Murty, Surya, Chang, Edwin, Gambhir, Sanjiv
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216937/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.122
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki